|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.76 CNY | -3.13% |
|
+0.86% | -34.48% |
Shaanxi Meibang Pharmaceutical Group Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 842.49 million compared to CNY 568.52 million a year ago. Net income was CNY 125.74 million compared to CNY 78.73 million a year ago.
Basic earnings per share from continuing operations was CNY 1.14 compared to CNY 0.78 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -34.48% | 219M | |
| -12.52% | 3.1B | |
| -45.71% | 1.46B | |
| -15.35% | 1.44B | |
| -21.79% | 1.42B | |
| -35.59% | 1.38B | |
| -13.03% | 1.19B | |
| -13.92% | 978M | |
| +59.89% | 938M | |
| -35.17% | 856M |
SHAANXI MEIBANG PHARMACEUTICAL GROUP CO., LTD. 
